<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25558" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Nasolacrimal Duct Obstruction</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Perez</surname>
            <given-names>Yomayra</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Patel</surname>
            <given-names>Bhupendra C.</given-names>
          </name>
          <aff>University of Utah</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mendez</surname>
            <given-names>Magda D.</given-names>
          </name>
          <aff>Lincoln Medical Center/Weil Cornell</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yomayra Perez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bhupendra Patel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Magda Mendez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25558.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Nasolacrimal duct obstruction (NLDO) or dacryostenosis is the most common disorder of the lacrimal system, and approximately 6 to 20 percent of newborns exhibit symptoms of this condition. Typically, NLDO presents in the first weeks or months of life with symptoms that begin when normal tear production starts, presenting with excessive tearing and ocular discharge. Erythema of the periorbital skin, upper and lower eyelids may result from irritation from tears and discharge due to inadequate drainage. As a result, the condition may mimic chronic unilateral conjunctivitis. This activity examines the presentation, evaluation, and management of nasolacrimal duct obstruction and stresses the role of an interprofessional team approach to the care of affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the typical exam findings in a patient with nasolacrimal duct obstruction.</p></list-item><list-item><p>Review how to properly evaluate for nasolacrimal duct obstruction.</p></list-item><list-item><p>Identify treatment considerations for patients with nasolacrimal duct obstruction.</p></list-item><list-item><p>Explain the importance of improving coordination amongst the interprofessional team to enhance the delivery of care for patients affected by nasolacrimal duct obstruction.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25558&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25558">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25558.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Nasolacrimal duct obstruction (NLDO) or dacryostenosis is the most common disorder of the lacrimal system.<xref ref-type="bibr" rid="article-25558.r1">[1]</xref>&#x000a0;Approximately 6% to 20% of newborns patients present with some symptoms.<xref ref-type="bibr" rid="article-25558.r2">[2]</xref>&#x000a0;Typically, NLDO presents more often in the first weeks or months of life with symptoms beginning when normal tear production occurs, presenting as excessive tearing and ocular discharge. Erythema of the periorbital skin, upper and lower eyelids may result from irritation and&#x000a0;rubbing&#x000a0;produced by dripping of tears and discharge due to inadequate drainage. As a&#x000a0;result,&#x000a0;the condition may be apparent as chronic unilateral conjunctivitis. Most the cases resolved spontaneously or with minimal intervention by the first year of life; however, unresolved cases need to be referred to the pediatric ophthalmologist for probing and&#x000a0;may&#x000a0;require surgical intervention. In children younger than 6 months of age, a conservative approach is&#x000a0;a typical&#x000a0;management. Massaging the lacrimal sac, eye drops, and topical antibiotics are commonly used, and surgical treatment is considered for patients whose symptoms persist after 12 months of age.<xref ref-type="bibr" rid="article-25558.r3">[3]</xref></p>
      </sec>
      <sec id="article-25558.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The lacrimal drainage structures form during the fifth week of gestation as a crease between the frontons and maxillary processes, known as the nasolacrimal groove or naso-optic fissure&#x000a0;10<bold>.</bold> A cord of ectodermal tissues separates from the surface and enters this groove. This tissue eventually canalizes and forms the lacrimal sac and nasolacrimal duct. This process of canalization usually begins by week 8&#x000a0;and is completed by birth. Tears are produced by the main and accessory lacrimal glands and drain medially into the puncta, then flow through the canaliculi to the lacrimal sac, and then through the nasolacrimal duct into the nose. Incomplete canalization is the most common cause of congenital nasolacrimal duct obstruction (NLDO) and occurs at the distal end resulting in an imperforate membrane at the valve of Hasner.<xref ref-type="bibr" rid="article-25558.r4">[4]</xref></p>
      </sec>
      <sec id="article-25558.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The prevalence of this condition is approximately 6% to 20% in infants. There is a high rate of spontaneous resolution of congenital nasolacrimal duct obstruction with approximately 70% of affected children being free of the symptoms by 3 months of age, and over 90% recovering by their first birthday. In one study, 20% of healthy infants showed evidence of defective lacrimal drainage during the first year of life. Spontaneous resolution occurs by 6 months of age in approximately 90% of infants with congenital nasolacrimal duct obstruction (NLDO). From those infants with persistent symptoms at 6 to 10 months of age, approximately two-thirds have&#x000a0;a resolution&#x000a0;within 6 months. The cases that persist beyond 12 months of&#x000a0;age&#x000a0;are likely to require probing of the lacrimal duct. A&#x000a0;study showed that those patients with significant nasolacrimal obstruction, meaning nonresponsive to two or more probing procedures, with or without intubation, 35% have nasolacrimal duct obstruction, 15% have&#x000a0;punctal&#x000a0;agenesis, 10% have congenital fistulas, and 5% have craniofacial defects.<xref ref-type="bibr" rid="article-25558.r5">[5]</xref>&#x000a0;The condition affects males and females equally. It has reported no difference in the racial incidence of congenital nasolacrimal system abnormalities.</p>
        <p>Infants at increased risk for this condition include those with trisomy 21, ectrodactyly-ectodermal dysplasia-cleft lip/palate (EEC) syndrome,&#x000a0;branchiooculofacial&#x000a0;syndrome, CHARGE (coloboma, heart anomaly, choanal atresia, and retardation, genital and ear anomalies) syndrome, and Goldenhar syndrome.</p>
      </sec>
      <sec id="article-25558.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Infants with congenital nasolacrimal duct obstruction (NLDO) present with a history of chronic or intermittent tearing and debris on the eyelashes. Conjunctival erythema is not characteristic although irritation from overflow tearing and chronic rubbing of the eyes may cause mild redness of the lower and upper eyelid. On physical examination, there is usually an increase in the size of the tear meniscus. Palpation of the lacrimal sac may cause reflux of tears and/or mucoid discharge onto the eye through the puncta.</p>
        <p>Congenital nasolacrimal anomalies, particularly obstruction, can lead to various clinical manifestations including infection due to stasis of fluid within the lacrimal system. Obstruction can partially&#x000a0;allow the duct to drain the tears produced, except in situations where increased tear production is present (wind, cold weather) and tear overflow results. The normal flora bacteria usually present&#x000a0;within&#x000a0;the tears do not cause problems because they are flushed readily into the nares. In NLDO, the stasis of fluid within the lacrimal sac creates a moist, warm environment favorable to bacterial growth.</p>
        <p>A few infants with NLDO present within the first few weeks of life with a more severe infection: acute dacryocystitis. Clinical findings include edema and erythema with distension of the lacrimal sac below the medial canthal tendon, and patients may have systemic signs of infection such as fever and irritability. This is a rare complication of isolated congenital NLDO. Acute dacryocystitis can be complicated by&#x000a0;preseptal&#x000a0;or orbital cellulitis, sepsis, or meningitis and should be treated promptly with systemic antibiotics. Although antibiotic therapy is frequently prescribed for dacryocystitis, the definitive treatment of dacryocystitis is usually surgical.</p>
      </sec>
      <sec id="article-25558.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Diagnosis is typically made by history and physical examination alone. If symptoms are intermittent and signs of abnormal tearing or "mattering" are not present at the time of examination, the dye disappearance test can be performed to help confirm the diagnosis. Begin by placing one&#x000a0;drop of fluorescein-stained saline in the inferior cul-de-sac of the patient's eyes and wipe away excess tears from the eyelids. Wait 5 minutes and inspect the eyes. The fluorescein should drain completely into the nose within 5 minutes if the lacrimal drainage system has no obstruction.</p>
      </sec>
      <sec id="article-25558.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The primary treatment of uncomplicated nasolacrimal duct obstruction (NLDO) is a regimen of nasolacrimal massage,&#x000a0;usually&#x000a0;2&#x000a0; to 3 times per day, accompanied by&#x000a0;a cleansing&#x000a0;of the lids with warm water and topical antibiotics; this will resolve the infection in 76% to 89% of cases.<xref ref-type="bibr" rid="article-25558.r6">[6]</xref><xref ref-type="bibr" rid="article-25558.r7">[7]</xref><xref ref-type="bibr" rid="article-25558.r8">[8]</xref>&#x000a0;Topical antibiotics are used for control of mucopurulent drainage, and a bland ophthalmic ointment may be used on the eyelids if the skin is macerated. In cases that do not resolve by age 6 to 10 months, lacrimal duct probing is performed by pediatric ophthalmology in the office (Bowman probe) or in the operating room (intranasal cysts or infection), depending on the age of the child.<xref ref-type="bibr" rid="article-25558.r9">[9]</xref>&#x000a0;During the procedure the physician&#x000a0;inserts&#x000a0;a probe or irrigation cannula and advances it through the lacrimal drainage system until it&#x000a0;touches&#x000a0;the obstruction; the probe is then pushed through the obstruction into the nose. Irrigation with fluorescein-stained saline is often achieved to warrant patency. If concomitant infection or cellulitis is present, systemic antibiotics should be used first, then probing is done. The advantages of early probing in the office setting are avoidance of general anesthesia, speedy resolution of symptoms, fewer&#x000a0;physician visits, fewer antibiotic prescriptions, and less costly procedures.</p>
      </sec>
      <sec id="article-25558.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis is broad and includes conjunctivitis, corneal abrasion, uveitis hemangiomas, dermoids, nasal gliomas, and infantile glaucoma. The absence of associated signs and symptoms distinguishes congenital nasolacrimal duct obstruction (NLDO)&#x000a0;from other causes of persistent tearing.</p>
        <p>Most infants with congenital NLDO&#x000a0;can be diagnosed and managed by the primary care practitioner. Referral to an ophthalmologist is warranted if the&#x000a0;diagnosis is uncertain, particularly if there is any concern of glaucoma or signs or symptoms of dacryocystitis or dacryocystocele.</p>
      </sec>
      <sec id="article-25558.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Infants with nasolacrimal duct obstruction initially present to the pediatrician, nurse practitioner or the primary care provider. It is important to refer these patients to an ophthalmologist for further workup because there are many causes.&#x000a0;The ophthalmic nurse should educate the caregiver on home care management; the primary treatment of uncomplicated nasolacrimal duct obstruction (NLDO) is a regimen of nasolacrimal massage,&#x000a0;usually&#x000a0;2&#x000a0; to 3 times per day, accompanied by&#x000a0;a cleansing&#x000a0;of the lids with warm water and topical antibiotics; this will resolve the infection in 76% to 89% of cases. When the conservative methods fail to relieve the obstruction, some type of surgery procedure is performed to relieve the blockage.&#x000a0;The advantages of early probing in the office setting are avoidance of general anesthesia, speedy resolution of symptoms, fewer&#x000a0;physician visits, fewer antibiotic prescriptions, and less costly procedures.</p>
      </sec>
      <sec id="article-25558.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25558&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25558">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/nasolacrimal-duct-obstruction/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25558">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25558/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25558">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-25558.s11">
        <fig id="article-25558.image.f1" position="float" orientation="portrait">
          <caption>
            <p>The Crigler Maneuver for Congenital Nasolacrimal Duct Obstruction. In this technique, the finger is inwardly pressed against the lacrimal sac, and the massaging movement is directed downward to elevate hydrostatic pressure within the lacrimal sac and the nasolacrimal duct. Contributed by BCK Patel, MD, FRCS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Crigler__technique" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-25558.s12">
        <fig id="article-25558.image.f2" position="float" orientation="portrait">
          <caption>
            <p>The Crigler Technique and the modified technique for the treatment of congenital nasolacrimal duct obstruction Contributed by Prof. Bhupendra C. K. Patel MD, FRCS</p>
          </caption>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Crigler__Technique__-__final.mp4" mime-subtype="mp4" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-25558.s13">
        <fig id="article-25558.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Punctal membrane caused by a chronic follicular conjunctivitis. Membranes may also develop in the presence of nasolacrimal duct obstruction or canaliculitis Contributed by Professor Bhupendra C. K. Patel MD, FRCS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="2__Punctal__membrane-bck__patel" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-25558.s14">
        <title>References</title>
        <ref id="article-25558.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ffooks</surname>
                <given-names>OO</given-names>
              </name>
            </person-group>
            <article-title>DACRYOCYSTITIS IN INFANCY.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1962</year>
            <month>Jul</month>
            <volume>46</volume>
            <issue>7</issue>
            <fpage>422</fpage>
            <page-range>422-34</page-range>
            <pub-id pub-id-type="pmid">18170798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25558.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>GUERRY</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>KENDIG</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Congenital impatency of the nasolacrimal duct.</article-title>
            <source>Arch Ophthal</source>
            <year>1948</year>
            <month>Feb</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>193</fpage>
            <page-range>193-204</page-range>
            <pub-id pub-id-type="pmid">18868825</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25558.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paul</surname>
                <given-names>TO</given-names>
              </name>
            </person-group>
            <article-title>Medical management of congenital nasolacrimal duct obstruction.</article-title>
            <source>J Pediatr Ophthalmol Strabismus</source>
            <year>1985</year>
            <season>Mar-Apr</season>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>68</fpage>
            <page-range>68-70</page-range>
            <pub-id pub-id-type="pmid">3989643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25558.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sevel</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Development and congenital abnormalities of the nasolacrimal apparatus.</article-title>
            <source>J Pediatr Ophthalmol Strabismus</source>
            <year>1981</year>
            <season>Sep-Oct</season>
            <volume>18</volume>
            <issue>5</issue>
            <fpage>13</fpage>
            <page-range>13-9</page-range>
            <pub-id pub-id-type="pmid">7299606</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25558.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Pediatric Eye Disease Investigator Group</collab>
              <name>
                <surname>Repka</surname>
                <given-names>MX</given-names>
              </name>
              <name>
                <surname>Melia</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Beck</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Chandler</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Fishman</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Goldblum</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Perla</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Quinn</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Silbert</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children younger than 4 years of age.</article-title>
            <source>J AAPOS</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>451</fpage>
            <page-range>451-5</page-range>
            <pub-id pub-id-type="pmid">18929305</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25558.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harris</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>DiClementi</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Congenital dacryocystocele.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1982</year>
            <month>Nov</month>
            <volume>100</volume>
            <issue>11</issue>
            <fpage>1763</fpage>
            <page-range>1763-5</page-range>
            <pub-id pub-id-type="pmid">7138344</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25558.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schnall</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Christian</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Conservative treatment of congenital dacryocele.</article-title>
            <source>J Pediatr Ophthalmol Strabismus</source>
            <year>1996</year>
            <season>Sep-Oct</season>
            <volume>33</volume>
            <issue>5</issue>
            <fpage>219</fpage>
            <page-range>219-22</page-range>
            <pub-id pub-id-type="pmid">8880613</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25558.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petersen</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Robb</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>The natural course of congenital obstruction of the nasolacrimal duct.</article-title>
            <source>J Pediatr Ophthalmol Strabismus</source>
            <year>1978</year>
            <season>Jul-Aug</season>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>246</fpage>
            <page-range>246-50</page-range>
            <pub-id pub-id-type="pmid">739359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25558.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Chandler</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Repka</surname>
                <given-names>MX</given-names>
              </name>
              <name>
                <surname>Hoover</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Melia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rychwalski</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Silbert</surname>
                <given-names>DI</given-names>
              </name>
              <collab>Pediatric Eye Disease Investigator Group</collab>
              <name>
                <surname>Beck</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Crouch</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Donahue</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Quinn</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Sala</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Schloff</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Frick</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Golden</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Lambert</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Tien</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Weakley</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Office probing for treatment of nasolacrimal duct obstruction in infants.</article-title>
            <source>J AAPOS</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <page-range>26-30</page-range>
            <pub-id pub-id-type="pmid">24568978</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
